Photocure   Report issue

Contributed to NME For profit Phase 2 Phase 3
Founded: Oslo Norway (1997)
Status: Left NME R&D (2015)

Organization Overview

First Clinical Trial
2001
NCT00052637
First Marketed Drug
2004
methyl aminolevulinate (metvixia)
First NDA Approval
2004
methyl aminolevulinate (metvixia)
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

PhotoCure | Photocure ASA | PHOTOCURE ASA